Evaluation of QT prolongation risk in newly approved medicinal products by EMA between 2009-2019

Firda Juhairiyah

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com

ImprintTerms of ServicePrivacy PolicyAccessibility